Synthetic Bone Graft Substitutes Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Synthetic Bone Graft Substitutes Pipeline Market Report Overview

Synthetic bone graft substitutes are used as alternatives for autograft and allograft bone. Major types of synthetic bone substitutes include calcium sulfate, calcium phosphate, tricalcium phosphate (TCP), and coralline hydroxyapatite. The second-generation products include bioactive glass, collagen-containing, and polymer-based bone substitutes.

The synthetic bone graft substitutes pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·       The United States

·       Europe

·       Taiwan

·       United Kingdom

·       Japan

Key Regulatory Paths ·       510(k)

·       CE

·       PMA

·       BOPA

·       Ninsho

Leading Companies ·       Acuitive Technologies Inc.

·       Amend Surgical, Inc.

·       Anika Therapeutics Inc.

·       Baxter International Inc.

·       Bio2 Technologies Inc

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Synthetic Bone Graft Substitutes Pipeline Market Segmentation by Territories

The key territories associated with the synthetic bone graft substitute pipeline market are Europe, the United States, Taiwan, Japan, and the United Kingdom among others. As of October 2024, the US had the highest number of synthetic bone graft substitutes pipeline products.

Synthetic Bone Graft Substitutes Pipeline Market Analysis by Territories, 2024 (%)

Synthetic Bone Graft Substitutes Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Synthetic Bone Graft Substitutes Pipeline Market

Download a Free Report Sample

Synthetic Bone Graft Substitutes Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the synthetic bone graft substitutes pipeline products market are 510(k), CE, PMA, BOPA, and Ninsho among others. As of October 2024, 510(k) was the most followed pathway for pipeline products in the synthetic bone graft substitutes market.

Synthetic Bone Graft Substitutes Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Synthetic Bone Graft Substitutes Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Synthetic Bone Graft Substitutes Pipeline Market

Download a Free Report Sample

Synthetic Bone Graft Substitutes Pipeline Market – Competitive Landscape

A few of the key companies associated with the synthetic bone graft substitutes pipeline market are Acuitive Technologies Inc., Amend Surgical, Inc., Anika Therapeutics Inc., Baxter International Inc., and Bio2 Technologies Inc. among others.

Acuitive Technologies Inc: Acuitive Technologies Inc. is a developer of surgical medical devices designed to help in surgeries. It is headquartered in Allendale, New Jersey, the US.

Baxter International Inc: Baxter International Inc. provides a range of healthcare products and services including sterile intravenous solutions, generic injectable pharmaceuticals, parenteral nutrition therapies, infusion systems and devices, inhaled anesthetics, and surgical hemostat and sealant products among others. Baxter distributes its products through a direct sales force and a network of independent distributors, drug wholesalers, specialty pharmacies, and other alternative site providers.

Key Companies in the Synthetic Bone Graft Substitutes Pipeline Market
Key Companies in the Synthetic Bone Graft Substitutes Pipeline MarketBuy the Full Report for More Company Insights into the Synthetic Bone Graft Substitutes Pipeline Market
Download a Free Report Sample

Segments Covered in the Report

Synthetic Bone Graft Substitutes Pipeline Market Territories Outlook (2024)

  • The United States
  • Europe
  • Taiwan
  • United Kingdom
  • Japan

Synthetic Bone Graft Substitutes Pipeline Market Regulatory Paths Outlook (2024)

  • 510(k)
  • CE
  • PMA
  • BOPA
  • Ninsho

Scope

The report provides:

  • Extensive coverage of the synthetic bone graft substitutes under development.
  • Details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities.
  • Reviews of the major players involved in the development of synthetic bone graft substitutes and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain competitive advantage.
  • Identify and understand important and diverse types of synthetic bone graft substitutes under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Acuitive Technologies Inc
Agenta Biotechnologies Inc (Inactive)
Amend Surgical, Inc.
Anika Therapeutics Inc
Baxter International Inc
Berkeley Advanced Biomaterials Inc
Bio2 Technologies Inc
BioGend Therapeutics Co Ltd
Biomatlante SA
Biorez Inc
Bonalive Biomaterials Ltd
Bone Solutions Inc
BoneGrafix, Inc.
BoneSupport AB
Calcitec, Inc.
Daewoong Pharmaceutical Co Ltd
Dimension Inx LLC
DSM Biomedical BV
Elute Inc
Eskisehir Osmangazi University
EternoGen Aesthetics LLC
Graftys SA
Industrie Biomediche Insubri SA
Innovoss Inc. (Inactive)
IRCCS San Raffaele Hospital
Isto Biologics
King's College London
Maxigen Biotech Inc
National Center of Innovation for Biomaterials in Orthopaedic Research
National University of Science and Technology MiSiS
OrthoMedex LLC
OssDsign AB
PolyPid Ltd
Polytechnic University of Catalonia
Pro Therapeutics LLC
Promimic AB
Prosidyan, Inc.
ReCaPP
RepRegen Ltd. (Inactive)
Revivicor Inc
Sanara MedTech Inc
Scil Technology GmbH
SDIP Innovations Pty Ltd
Silk Biomaterials Srl
Sofregen Medical Inc
Soteira Inc
Sree Chitra Tirunal Institute for Medical Sciences & Technology
Stanford University
SurGenTec LLC
University of California San Diego
University of Edinburgh
Wright Medical Group NV (Inactive)
Xtant Medical Holdings Inc

Table of Contents

|1 Table of Contents

|1.1 List of Tables

|1.2 List of Figures

2 Introduction

2.1 Synthetic Bone Graft Substitutes Overview

3 Products under Development

3.1 Synthetic Bone Graft Substitutes – Pipeline Products by Stage of Development

3.2 Synthetic Bone Graft Substitutes – Pipeline Products by Territory

3.3 Synthetic Bone Graft Substitutes – Pipeline Products by Regulatory Path

3.4 Synthetic Bone Graft Substitutes – Pipeline Products by Estimated Approval Date

3.5 Synthetic Bone Graft Substitutes – Ongoing Clinical Trials

4 Synthetic Bone Graft Substitutes – Pipeline Products under Development by Companies

4.1 Synthetic Bone Graft Substitutes Companies – Pipeline Products by Stage of Development

4.2 Synthetic Bone Graft Substitutes – Pipeline Products by Stage of Development

5 Synthetic Bone Graft Substitutes Companies and Product Overview

5.1 Acuitive Technologies Inc Company Overview

5.1.1 Acuitive Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

5.2 Agenta Biotechnologies Inc (Inactive) Company Overview

5.2.1 Agenta Biotechnologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.3 Amend Surgical, Inc. Company Overview

5.3.1 Amend Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.4 Anika Therapeutics Inc Company Overview

5.4.1 Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.5 Baxter International Inc Company Overview

5.5.1 Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview

5.6 Berkeley Advanced Biomaterials Inc Company Overview

5.6.1 Berkeley Advanced Biomaterials Inc Pipeline Products & Ongoing Clinical Trials Overview

5.7 Bio2 Technologies Inc Company Overview

5.7.1 Bio2 Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

5.8 BioGend Therapeutics Co Ltd Company Overview

5.8.1 BioGend Therapeutics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.9 Biomatlante SA Company Overview

5.9.1 Biomatlante SA Pipeline Products & Ongoing Clinical Trials Overview

5.10 Biorez Inc Company Overview

5.10.1 Biorez Inc Pipeline Products & Ongoing Clinical Trials Overview

5.11 Bonalive Biomaterials Ltd Company Overview

5.11.1 Bonalive Biomaterials Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.12 Bone Solutions Inc Company Overview

5.12.1 Bone Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview

5.13 BoneGrafix, Inc. Company Overview

5.13.1 BoneGrafix, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.14 BoneSupport AB Company Overview

5.14.1 BoneSupport AB Pipeline Products & Ongoing Clinical Trials Overview

5.15 Calcitec, Inc. Company Overview

5.15.1 Calcitec, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.16 Daewoong Pharmaceutical Co Ltd Company Overview

5.16.1 Daewoong Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.17 Dimension Inx LLC Company Overview

5.17.1 Dimension Inx LLC Pipeline Products & Ongoing Clinical Trials Overview

5.18 DSM Biomedical BV Company Overview

5.18.1 DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview

5.19 Elute Inc Company Overview

5.19.1 Elute Inc Pipeline Products & Ongoing Clinical Trials Overview

5.20 Eskisehir Osmangazi University Company Overview

5.20.1 Eskisehir Osmangazi University Pipeline Products & Ongoing Clinical Trials Overview

5.21 EternoGen Aesthetics LLC Company Overview

5.21.1 EternoGen Aesthetics LLC Pipeline Products & Ongoing Clinical Trials Overview

5.22 Graftys SA Company Overview

5.22.1 Graftys SA Pipeline Products & Ongoing Clinical Trials Overview

5.23 Industrie Biomediche Insubri SA Company Overview

5.23.1 Industrie Biomediche Insubri SA Pipeline Products & Ongoing Clinical Trials Overview

5.24 Innovoss Inc. (Inactive) Company Overview

5.24.1 Innovoss Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.25 IRCCS San Raffaele Hospital Company Overview

5.25.1 IRCCS San Raffaele Hospital Pipeline Products & Ongoing Clinical Trials Overview

5.26 Isto Biologics Company Overview

5.26.1 Isto Biologics Pipeline Products & Ongoing Clinical Trials Overview

5.27 King’s College London Company Overview

5.27.1 King’s College London Pipeline Products & Ongoing Clinical Trials Overview

5.28 Maxigen Biotech Inc Company Overview

5.28.1 Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview

5.29 National Center of Innovation for Biomaterials in Orthopaedic Research Company Overview

5.29.1 National Center of Innovation for Biomaterials in Orthopaedic Research Pipeline Products & Ongoing Clinical Trials Overview

5.30 National University of Science and Technology MiSiS Company Overview

5.30.1 National University of Science and Technology MiSiS Pipeline Products & Ongoing Clinical Trials Overview

5.31 OrthoMedex LLC Company Overview

5.31.1 OrthoMedex LLC Pipeline Products & Ongoing Clinical Trials Overview

5.32 OssDsign AB Company Overview

5.32.1 OssDsign AB Pipeline Products & Ongoing Clinical Trials Overview

5.33 PolyPid Ltd Company Overview

5.33.1 PolyPid Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.34 Polytechnic University of Catalonia Company Overview

5.34.1 Polytechnic University of Catalonia Pipeline Products & Ongoing Clinical Trials Overview

5.35 Pro Therapeutics LLC Company Overview

5.35.1 Pro Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview

5.36 Promimic AB Company Overview

5.36.1 Promimic AB Pipeline Products & Ongoing Clinical Trials Overview

5.37 Prosidyan, Inc. Company Overview

5.37.1 Prosidyan, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.38 ReCaPP Company Overview

5.38.1 ReCaPP Pipeline Products & Ongoing Clinical Trials Overview

5.39 RepRegen Ltd. (Inactive) Company Overview

5.39.1 RepRegen Ltd. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.40 Revivicor Inc Company Overview

5.40.1 Revivicor Inc Pipeline Products & Ongoing Clinical Trials Overview

5.41 Sanara MedTech Inc Company Overview

5.41.1 Sanara MedTech Inc Pipeline Products & Ongoing Clinical Trials Overview

5.42 Scil Technology GmbH Company Overview

5.42.1 Scil Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview

5.43 SDIP Innovations Pty Ltd Company Overview

5.43.1 SDIP Innovations Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.44 Silk Biomaterials Srl Company Overview

5.44.1 Silk Biomaterials Srl Pipeline Products & Ongoing Clinical Trials Overview

5.45 Sofregen Medical Inc Company Overview

5.45.1 Sofregen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.46 Soteira Inc Company Overview

5.46.1 Soteira Inc Pipeline Products & Ongoing Clinical Trials Overview

5.47 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview

5.47.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview

5.48 Stanford University Company Overview

5.48.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview

5.49 SurGenTec LLC Company Overview

5.49.1 SurGenTec LLC Pipeline Products & Ongoing Clinical Trials Overview

5.50 University of California San Diego Company Overview

5.50.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview

5.51 University of Edinburgh Company Overview

5.51.1 University of Edinburgh Pipeline Products & Ongoing Clinical Trials Overview

5.52 Wright Medical Group NV (Inactive) Company Overview

5.52.1 Wright Medical Group NV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.53 Xtant Medical Holdings Inc Company Overview

5.53.1 Xtant Medical Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview

6 Synthetic Bone Graft Substitutes- Recent Developments

6.1 Sep 26, 2024: Solario Study Meets Its Primary Endpoints – Bone Substitute With Local Antibiotics Enables Reduced Systemic Antibiotic Treatment

6.2 Sep 12, 2024: Stryker Receives FDA 510(k) Clearance for Vitoss BA Bimodal Bone Graft Substitute

6.3 Sep 12, 2024: Biocomposites to Distribute its NanoBone Product Range in the UK

6.4 Sep 09, 2024: Stryker Spine Receives Additional FDA 510(k) Clearance for Vitoss BiModal Bioactive Bone Graft Substitute Foam Strip

6.5 Sep 09, 2024: Baxter Names Former Auto Exec Jay Craig to Its Board

6.6 Aug 30, 2024: Abyrx Receives Additional 510(k) Clearance For MONTAGE-XT Settable Resorbable Hemostatic Bone Putty

6.7 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

6.8 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

6.9 Aug 12, 2024: Baxter International Receives Additional FDA 510(k) Clearance for Actifuse Shape

6.10 Aug 12, 2024: Baxter International Receives Additional FDA 510(k) Clearance for Actifuse MIS Bone Graft Delivery System

6.11 Aug 12, 2024: Baxter International Receives 510(K) Clearance for Actifuse Advanced Bone MatriX

6.12 Aug 12, 2024: Baxter Healthcare receives 510(K) Clearance for Altapore Shape

6.13 Aug 12, 2024: Baxter Healthcare Receives additional 510(K) Clearance for Altapore

6.14 Aug 07, 2024: Zimmer Biomet Announces Second Quarter 2024 Financial Results

6.15 Jul 31, 2024: ATEC Reports Second Quarter 2024 Financial Results And Raises Full-Year Guidance

6.16 Jul 17, 2024: Baxter to Host Second-Quarter 2024 Financial Results Conference Call for Investors

6.17 Jul 15, 2024: Integra LifeSciences to Host Second Quarter 2024 Financial Results Conference Call on July 29, 2024

6.18 Jul 10, 2024: Kuros Biosciences Receives Additional 510(K) Clearance For MagnetOs Easypack Putty

6.19 Jul 10, 2024: ATEC to Report Second Quarter Financial Results on July 31, 2024

6.20 Jul 02, 2024: XeroThera Receives 510(K) Clearance For Xerosyn

6.21 Jul 02, 2024: SpineCraft and Spartan Medical Enter Into Strategic Partnership

6.22 Jul 01, 2024: Stryker to Announce Financial Results for its Second Quarter of Fiscal Year 2024

6.23 Jun 25, 2024: Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in Spine, Indicating Superiority Over Autograft

6.24 Jun 13, 2024: Medtronic Confirms Global Layoffs

6.25 Jun 12, 2024: Biogennix Announces Publication of a Scientific Study on Its Advanced Bone Graft Technology

6.26 May 30, 2024: 5,000 patients treated with OssDsign Catalyst in the U.S.

6.27 May 17, 2024: BIOGENNIX Receives Additional 510(K) Clearance For Morpheus Moldable

6.28 May 17, 2024: BIOGENNIX Receives 510(K) Clearance For Agilon Moldable

6.29 May 08, 2024: Biogennix Receives FDA Clearance for Expanded Use of Agilon Moldable and Morpheus Moldable Products

6.30 May 07, 2024: Baxter to Present at Bank of America 2024 Health Care Conference

6.31 Apr 24, 2024: Kuros Reports Corporate Highlights as of Q1 2024 Including Increase in Direct MagnetOs Sales

6.32 Apr 16, 2024: Kuros Biosciences Receives Additional FDA 510(k) Clearance for MagnetOs Putty

6.33 Apr 02, 2024: NuVasive Receives Additional 510(K) Clearance For NuVasive

6.34 Mar 22, 2024: BoneSupport Receives FDA 510(k) Clearance for Cerament|G

6.35 Mar 19, 2024: Orthorebirth Receives Additional 510(K) Clearance For Rebossis

6.36 Mar 19, 2024: BoneSupport Receives Additional 510(K) Clearance For Cerament Bone Void Filler

6.37 Mar 13, 2024: Sanara Medtech Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Dates

6.38 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference

6.39 Mar 08, 2024: SurGenTec’s OsteoFlo HydroPutty obtains FDA 510(k) clearance

6.40 Feb 27, 2024: Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024

6.41 Feb 17, 2024: Bone Solutions Receives Additional 510(K) Clearance For Mg OSTEOINJECT

6.42 Feb 15, 2024: Bone Solutions Receives Additional 510(K) Clearance For Mg OSTEOREVIVE

6.43 Feb 13, 2024: Bone Solutions Receives 510(k) Clearance for Expanded Indications of Use for Mg OSTEOCRETE in Intervertebral Body Fusion Procedures

6.44 Jan 31, 2024: Kuros Biosciences Receives US FDA 510K Clearance for MagnetOs Granules for Interbody use and Regulatory Clearance of MagnetOs Granules and MagnetOs Putty in New Zealand

6.45 Jan 29, 2024: Kuros Biosciences Receives Additional 510(K) Clearance For MagnetOs Granules

6.46 Jan 24, 2024: 12-Month Data from the Clinical Study of Ossdsign Catalyst Published in Biomedical Journal of Scientific & Technical Research

6.47 Jan 16, 2024: Biocomposites Expands Its International Presence by Opening New Sales and Distribution Office in Italy

6.48 Jan 09, 2024: Anika Therapeutics Received Additional 510(K) Clearance For Tactoset Injectable Bone Substitute

6.49 Jan 09, 2024: Ossdsign Reports Exceptional Data from the Clinical Study Top Fusion

6.50 Jan 04, 2024: Kuros Biosciences Announces Three Advancements Related to its MagnetOs Portfolio Including Impressive Fusion Data from MAXA Prospective Randomized Clinical Trial and Two 510(k) Clearances from FDA

6.51 Jan 04, 2024: Baxter to Host Fourth-Quarter 2023 Financial Results Conference Call for Investors

6.52 Dec 27, 2023: Kuros Biosciences Receives an Additional 510(K) Clearance For MagnetOs Easypack Putty

6.53 Dec 20, 2023: Bioventus Receives Additional FDA (510k) Clearance For Signafuse Bioactive Bone Graft

6.54 Nov 28, 2023: Kuros Biosciences Receives FDA Clearance for Use of MagnetOs in Interbody Spinal Cages

6.55 Nov 21, 2023: Kuros Biosciences Receives Additional 510(K) Clearance For MagnetOs Flex Matrix

6.56 Oct 26, 2023: SurGenTec Receives 510(K) Clearance For OsteoFlo HydroPutty

6.57 Oct 16, 2023: SeaSpine Orthopedics Receives Additional 510(K) Clearance For Cove Strip

6.58 Oct 13, 2023: Orthofix’s OsteoCove graft receives US FDA 510k clearance

6.59 Oct 12, 2023: SeaSpine Orthopedics Receives 510(K) Clearance For OsteoCove Strip

6.60 Oct 10, 2023: Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023

6.61 Oct 09, 2023: Stryker to Host Investor Day

7 Appendix

7.1 Methodology

7.2 About GlobalData

7.3 Contact Us

7.4 Disclaimer

Table

Synthetic Bone Graft Substitutes – Pipeline Products by Stage of Development

Synthetic Bone Graft Substitutes – Pipeline Products by Territory

Synthetic Bone Graft Substitutes – Pipeline Products by Regulatory Path

Synthetic Bone Graft Substitutes – Pipeline Products by Estimated Approval Date

Synthetic Bone Graft Substitutes – Ongoing Clinical Trials

Synthetic Bone Graft Substitutes Companies – Pipeline Products by Stage of Development

Synthetic Bone Graft Substitutes – Pipeline Products by Stage of Development

Acuitive Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

Citrefoam – Product Status

Citrefoam – Product Description

Agenta Biotechnologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

B-247 Cranial Bone Graft Implant – Product Status

B-247 Cranial Bone Graft Implant – Product Description

Amend Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Biomimetic Bone – Product Status

Biomimetic Bone – Product Description

Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

Hyalobone – Product Status

Hyalobone – Product Description

Hyalograft C Autograft – Product Status

Hyalograft C Autograft – Product Description

Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview

Synthetic Bone Graft – Spinal – Product Status

Synthetic Bone Graft – Spinal – Product Description

Berkeley Advanced Biomaterials Inc Pipeline Products & Ongoing Clinical Trials Overview

CPA Ceramics – Product Status

CPA Ceramics – Product Description

HAP Ceramics – Product Status

HAP Ceramics – Product Description

Bio2 Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

Vitrium – Hammertoe Correction – Product Status

Vitrium – Hammertoe Correction – Product Description

Vitrium – Radial Osteotomy – Product Status

Vitrium – Radial Osteotomy – Product Description

Vitrium – Wrist Fracture Revision – Product Status

Vitrium – Wrist Fracture Revision – Product Description

BioGend Therapeutics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

OIF – Non-Union Bone Fracture – Product Status

OIF – Non-Union Bone Fracture – Product Description

OIF/ß-TCP – Block Form – Product Status

OIF/ß-TCP – Block Form – Product Description

OIF/ß-TCP – Granular Form – Product Status

OIF/ß-TCP – Granular Form – Product Description

BioGend Therapeutics Co Ltd – Ongoing Clinical Trials Overview

OIF/ß-TCP – Granular Form – A Randomized, Evaluator-blinded, Controlled Study to Evaluate the Safety and Clinical Performance of OIF/ß-TCP in Patients with Open Tibial Fractures in Need of Bone Grafting

Biomatlante SA Pipeline Products & Ongoing Clinical Trials Overview

Osteoconductive Resorbable Composite – Product Status

Osteoconductive Resorbable Composite – Product Description

Biorez Inc Pipeline Products & Ongoing Clinical Trials Overview

L-C Ligament – Product Status

L-C Ligament – Product Description

Bonalive Biomaterials Ltd Pipeline Products & Ongoing Clinical Trials Overview

S53P4 BonAlive Granules – Product Status

S53P4 BonAlive Granules – Product Description

Bonalive Biomaterials Ltd – Ongoing Clinical Trials Overview

S53P4 BonAlive Granules – Effectiveness of Two Bone Substitutes, Natural and Synthetic, in Preserving the Alveolar Ridge of Single-rooted Teeth: a Pilot Single-blind, Parallel Randomised Controlled Trial

S53P4 BonAlive Granules – Short- and Medium-term Evaluation of Mastoid Filling Using Bioactive Glass

Bone Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview

Osteocrete – Bone Anchor – Product Status

Osteocrete – Bone Anchor – Product Description

OsteoCrete – Cranial – Product Status

OsteoCrete – Cranial – Product Description

OsteoCrete – Maxillofacial – Product Status

OsteoCrete – Maxillofacial – Product Description

OsteoCrete – Non Load Bearing Spine – Product Status

OsteoCrete – Non Load Bearing Spine – Product Description

BoneGrafix, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Solid Bone Block – Product Status

Solid Bone Block – Product Description

BoneSupport AB Pipeline Products & Ongoing Clinical Trials Overview

Cerament + Bisphosphonate – Product Status

Cerament + Bisphosphonate – Product Description

Cerament|G – Product Status

Cerament|G – Product Description

Gelatin/Cerament – Product Status

Gelatin/Cerament – Product Description

BoneSupport AB – Ongoing Clinical Trials Overview

Cerament|G – A Post-Market Prospective Cohort Study on Subjects Receiving CERAMENT G as Part of the Surgical Treatment of Osteomyelitis in a Single-Stage Procedure

Cerament|G – CERAMENT G Device Registry

Cerament|G – Evaluation of the Efficiency of the Bone Substitute Cerament-G Locally Delivering Gentamicin in the Treatment of Chronic Osteomyelitis of Long Bones: Randomized Multicentre Study in the CRIOAc Network – CONVICTION Study

Cerament|G – Two-stage Treatment of Large Bone Defects with Cerament G and Cerament V plus Auto and/or Allograft Using the Masquelet Technique as Salvage Therapy after Bone Resection in Patients with Septic Pseudarthrosis

Calcitec, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Corticell – Product Status

Corticell – Product Description

Daewoong Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Bongros HA – Product Status

Bongros HA – Product Description

Dimension Inx LLC Pipeline Products & Ongoing Clinical Trials Overview

Hyperelastic Bone – Product Status

Hyperelastic Bone – Product Description

DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview

Structural Synthetic Bone Graft – Product Status

Structural Synthetic Bone Graft – Product Description

Elute Inc Pipeline Products & Ongoing Clinical Trials Overview

EP Granules With Tobramycin – Product Status

EP Granules With Tobramycin – Product Description

Eskisehir Osmangazi University Pipeline Products & Ongoing Clinical Trials Overview

Antimicrobial Synthetic Bone Graft – Product Status

Antimicrobial Synthetic Bone Graft – Product Description

EternoGen Aesthetics LLC Pipeline Products & Ongoing Clinical Trials Overview

Collagen Scaffold – Orthopedic Procedures – Product Status

Collagen Scaffold – Orthopedic Procedures – Product Description

Graftys SA Pipeline Products & Ongoing Clinical Trials Overview

GRFT-M04 – Product Status

GRFT-M04 – Product Description

GRFT-R02 – Product Status

GRFT-R02 – Product Description

Industrie Biomediche Insubri SA Pipeline Products & Ongoing Clinical Trials Overview

SmartBonePep – Product Status

SmartBonePep – Product Description

Innovoss Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Synthetic Bone Material – Product Status

Synthetic Bone Material – Product Description

IRCCS San Raffaele Hospital Pipeline Products & Ongoing Clinical Trials Overview

Tissue Repair Composite Scaffold – Product Status

Tissue Repair Composite Scaffold – Product Description

Isto Biologics Pipeline Products & Ongoing Clinical Trials Overview

InQu Bone Graft Extender And Substitute – Chondral Defects – Product Status

InQu Bone Graft Extender And Substitute – Chondral Defects – Product Description

King’s College London Pipeline Products & Ongoing Clinical Trials Overview

Synthetic Bone Composite – Product Status

Synthetic Bone Composite – Product Description

Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview

MaxiSetin – Product Status

MaxiSetin – Product Description

National Center of Innovation for Biomaterials in Orthopaedic Research Pipeline Products & Ongoing Clinical Trials Overview

Composite Bone Graft Substitute – Product Status

Composite Bone Graft Substitute – Product Description

National University of Science and Technology MiSiS Pipeline Products & Ongoing Clinical Trials Overview

Hybrid Bone Implant – Product Status

Hybrid Bone Implant – Product Description

OrthoMedex LLC Pipeline Products & Ongoing Clinical Trials Overview

Cancellous Bone Allograft – Product Status

Cancellous Bone Allograft – Product Description

OssDsign AB Pipeline Products & Ongoing Clinical Trials Overview

MaxSi Graft Granules – Product Status

MaxSi Graft Granules – Product Description

MaxSi Graft Putty – Product Status

MaxSi Graft Putty – Product Description

PolyPid Ltd Pipeline Products & Ongoing Clinical Trials Overview

D-Plex1000 – Product Status

D-Plex1000 – Product Description

Polytechnic University of Catalonia Pipeline Products & Ongoing Clinical Trials Overview

Bone Regeneration Foam – Product Status

Bone Regeneration Foam – Product Description

Pro Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview

Tissue-Engineered Rotator Cuff Tendon Graft – Product Status

Tissue-Engineered Rotator Cuff Tendon Graft – Product Description

Promimic AB Pipeline Products & Ongoing Clinical Trials Overview

HAnano Bone – Product Status

HAnano Bone – Product Description

Prosidyan, Inc. Pipeline Products & Ongoing Clinical Trials Overview

FIBERGRAFT AERIDYAN Matrix Bone Graft Substitute – Product Status

FIBERGRAFT AERIDYAN Matrix Bone Graft Substitute – Product Description

ReCaPP Pipeline Products & Ongoing Clinical Trials Overview

ReCapp Putty – Product Status

ReCapp Putty – Product Description

RepRegen Ltd. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Bone Graft Substitute – Load Bearing – Product Status

Bone Graft Substitute – Load Bearing – Product Description

StronBone-P – Product Status

StronBone-P – Product Description

Revivicor Inc Pipeline Products & Ongoing Clinical Trials Overview

Tendon – ACL Repair – Product Status

Tendon – ACL Repair – Product Description

Sanara MedTech Inc Pipeline Products & Ongoing Clinical Trials Overview

Bone Void Filler – Product Status

Bone Void Filler – Product Description

Scil Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview

ST01 Bone Graft Substitute Material – Product Status

ST01 Bone Graft Substitute Material – Product Description

SDIP Innovations Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview

JAZBI – Product Status

JAZBI – Product Description

Silk Biomaterials Srl Pipeline Products & Ongoing Clinical Trials Overview

SILKBridge – Bone Grafting – Product Status

SILKBridge – Bone Grafting – Product Description

Sofregen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

SeriACL Scaffold – Product Status

SeriACL Scaffold – Product Description

SeriCuff Scaffold – Product Status

SeriCuff Scaffold – Product Description

Soteira Inc Pipeline Products & Ongoing Clinical Trials Overview

Nanotechnology Bone Biomaterial – Spinal Repair – Product Status

Nanotechnology Bone Biomaterial – Spinal Repair – Product Description

Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview

Bioceramic Cage – Product Status

Bioceramic Cage – Product Description

Stanford University Pipeline Products & Ongoing Clinical Trials Overview

Bioactive Synthetic Bone Graft – Bone Healing – Product Status

Bioactive Synthetic Bone Graft – Bone Healing – Product Description

SurGenTec LLC Pipeline Products & Ongoing Clinical Trials Overview

OsteoFlo HydroFiber – Product Status

OsteoFlo HydroFiber – Product Description

OsteoFlo NanoPutty-Quadphasic Synthetic Bone Graft – Product Status

OsteoFlo NanoPutty-Quadphasic Synthetic Bone Graft – Product Description

University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview

Synthetic Bone Graft – Product Status

Synthetic Bone Graft – Product Description

University of Edinburgh Pipeline Products & Ongoing Clinical Trials Overview

Shapeable Foam – Bone Repair – Product Status

Shapeable Foam – Bone Repair – Product Description

Wright Medical Group NV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Augment Rotator Cuff Graft – Product Status

Augment Rotator Cuff Graft – Product Description

Xtant Medical Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview

Monetite Granules Based Bone Graft – Product Status

Monetite Granules Based Bone Graft – Product Description

Glossary

Figures

Synthetic Bone Graft Substitutes – Pipeline Products by Stage of Development

Synthetic Bone Graft Substitutes – Pipeline Products by Territory

Synthetic Bone Graft Substitutes – Pipeline Products by Regulatory Path

Synthetic Bone Graft Substitutes – Pipeline Products by Estimated Approval Date

Synthetic Bone Graft Substitutes – Ongoing Clinical Trials

Frequently asked questions

Synthetic Bone Graft Substitutes Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Synthetic Bone Graft Substitutes Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Synthetic Bone Graft Substitutes Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Synthetic Bone Graft Substitutes Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.